ABBOTT LABORATORIES (ABT) Stock Analyst Ratings
NYSE:ABT - US0028241000 - Common Stock
131.49 USD
-0.1 (-0.08%)
ChartMill assigns a Buy % Consensus number of 79% to ABT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 144.34. This target is 9.77% above the current price.
ABT was analyzed by 35 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about ABT.
In the previous month the buy percentage consensus was at a similar level.
ABT was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-18 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-07-18 | BTIG | Maintains | Buy -> Buy |
| 2025-07-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-18 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-18 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-16 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-07-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-04-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-17 | Stifel | Maintains | Buy -> Buy |
| 2025-04-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-17 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-04-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-17 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-04-17 | Jefferies | Maintains | Hold -> Hold |
| 2025-03-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-04 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-04 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-27 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-23 | UBS | Maintains | Buy -> Buy |
| 2025-01-23 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-23 | Stifel | Maintains | Buy -> Buy |
| 2025-01-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-17 | Bernstein | Maintains | Outperform -> Outperform |
| 2024-10-17 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-10-17 | UBS | Maintains | Buy -> Buy |